INTERPACE BIOSCIENCES, INC. Deferred Tax Assets, Valuation Allowance
INTERPACE BIOSCIENCES, INC. (IDXGD) had Deferred Tax Assets, Valuation Allowance of $9.77 million as of 2025-12-31, per its 10-K filed 2026-03-30.
Financial Statements › Notes › Income Taxes › Components of Deferred Tax Assets and Liabilities › Deferred Tax Assets, Net › Deferred Tax Assets, Net of Valuation Allowance
us-gaap:DeferredTaxAssetsValuationAllowance · last filed 2026-03-30
- 2025-12-31: Deferred Tax Assets, Valuation Allowance $9.77M.
- 2024-12-31: Deferred Tax Assets, Valuation Allowance $35.07M.
- 2023-12-31: Deferred Tax Assets, Valuation Allowance $36.91M; Deferred Tax Assets, Valuation Allowance as first filed $38.65M.
- 2022-12-31: Deferred Tax Assets, Valuation Allowance $38.26M.
| Period end | Deferred Tax Assets, Valuation Allowance | Deferred Tax Assets, Valuation Allowance as first filed |
|---|---|---|
| 2025-12-31 | $9.77M 10-K · filed 2026-03-30 | |
| 2024-12-31 | $35.07M 10-K · filed 2026-03-30 | |
| 2023-12-31 | $36.91M 10-K · filed 2025-03-31 | $38.65M 10-K · filed 2024-04-01 |
| 2022-12-31 | $38.26M 10-K · filed 2024-04-01 | |
| 2021-12-31 | $33.17M 10-K · filed 2023-03-27 | |
| 2020-12-31 | $23.68M 10-K · filed 2022-03-31 | |
| 2019-12-31 | $17.03M 10-K · filed 2021-04-01 | |
| 2018-12-31 | $43.57M 10-K · filed 2019-03-21 | |
| 2017-12-31 | $42.16M 10-K · filed 2019-03-21 |